These effects mirror other known DNA-carrier molecules such as LL37 and HMGB1, which enhance DNA uptake and immune recognition in diseases like systemic lupus erythematosus (SLE) and psoriasis [21]. Here, CAMP is linked to systemic lupus erythematosus.